Thermo Fisher’s New Array Supports Population-Scale Disease Studies and Pharmacogenomics Research
The array combines four assays: SNP genotyping, whole genome copy number variant detection, fixed copy number discovery, blood and HLA typing
Read MorePosted by Andy Lundin | Jan 4, 2024 | Microarray Systems |
The array combines four assays: SNP genotyping, whole genome copy number variant detection, fixed copy number discovery, blood and HLA typing
Read MorePosted by Andy Lundin | Jan 3, 2024 | Covid 19 |
This research aims to improve the understanding of how maternal antibodies against SARS-CoV-2 are transferred to and persist in newborns.
Read MorePosted by Andy Lundin | Dec 28, 2023 | Clinical Chemistry, Sequencing Systems, Unknown Origin & Other Cancer Types |
Findings from NGS suggest that revising cancer care guidelines could allow many more patients to benefit from immunotherapy treatment.
Read MorePosted by Chris Wolski | Dec 26, 2023 | Company News |
RetinalGeniX Technologies Inc., has contracted with MEDsan, Inc. to provide diagnostic testing...
Read MorePosted by Andy Lundin | Dec 20, 2023 | Diagnostic Technologies |
The AMP published a report that explores specific considerations for a slice testing strategy for diagnostics.
Read More